FDA NDC Directory · JSON-LD · Markdown

Pradaxa

NDC 0597-0360 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic namedabigatran etexilate mesylate
Labeler / ManufacturerBoehringer Ingelheim Pharmaceuticals Inc.
Marketing categoryNew Drug Application (innovator) · App NDA022512
Dosage form / routeCAPSULE · ORAL
Active ingredientsDABIGATRAN ETEXILATE MESYLATE (150 mg/1)
Marketing started20170728
Package count2

External sources

Source: openFDA. Public-domain (CC0).